Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP186311.RABkMhB_lgOmXv01zzbbT1M4tDCL8icwOD_5dU7rilW_U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP186311.RABkMhB_lgOmXv01zzbbT1M4tDCL8icwOD_5dU7rilW_U130_assertion type Assertion NP186311.RABkMhB_lgOmXv01zzbbT1M4tDCL8icwOD_5dU7rilW_U130_head.
- NP186311.RABkMhB_lgOmXv01zzbbT1M4tDCL8icwOD_5dU7rilW_U130_assertion description "[Our analysis shows that NNMT, ITLN1, LUM, CFD, and TSPAN8 in combination with other known markers, such as CRP, could be evaluated as a panel of biomarkers of POAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP186311.RABkMhB_lgOmXv01zzbbT1M4tDCL8icwOD_5dU7rilW_U130_provenance.
- NP186311.RABkMhB_lgOmXv01zzbbT1M4tDCL8icwOD_5dU7rilW_U130_assertion evidence source_evidence_literature NP186311.RABkMhB_lgOmXv01zzbbT1M4tDCL8icwOD_5dU7rilW_U130_provenance.
- NP186311.RABkMhB_lgOmXv01zzbbT1M4tDCL8icwOD_5dU7rilW_U130_assertion SIO_000772 22721676 NP186311.RABkMhB_lgOmXv01zzbbT1M4tDCL8icwOD_5dU7rilW_U130_provenance.
- NP186311.RABkMhB_lgOmXv01zzbbT1M4tDCL8icwOD_5dU7rilW_U130_assertion wasDerivedFrom befree-20140225 NP186311.RABkMhB_lgOmXv01zzbbT1M4tDCL8icwOD_5dU7rilW_U130_provenance.
- NP186311.RABkMhB_lgOmXv01zzbbT1M4tDCL8icwOD_5dU7rilW_U130_assertion wasGeneratedBy ECO_0000203 NP186311.RABkMhB_lgOmXv01zzbbT1M4tDCL8icwOD_5dU7rilW_U130_provenance.